KILIÇKAP, S. Et Al. 2018. Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey. IASLC 19th World Conference on Lung Cancer (WCLC 2018) , (Toronto, Canada).

KILIÇKAP, S., ÖZTÜRK, A., KARADURMUŞ, N., KORKMAZ, T., YUMUK, P. F., ÇİÇİN, İ., ... PAYDAŞ, S.(2018). Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey . IASLC 19th World Conference on Lung Cancer (WCLC 2018), Toronto, Canada

KILIÇKAP, SAADETTİN Et Al. "Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey," IASLC 19th World Conference on Lung Cancer (WCLC 2018), Toronto, Canada, 2018

KILIÇKAP, SAADETTİN Et Al. "Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey." IASLC 19th World Conference on Lung Cancer (WCLC 2018) , Toronto, Canada, 2018

KILIÇKAP, S. Et Al. (2018) . "Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey." IASLC 19th World Conference on Lung Cancer (WCLC 2018) , Toronto, Canada.

@conferencepaper{conferencepaper, author={SAADETTİN KILIÇKAP Et Al. }, title={Crizotinib Efficacy in ALK-positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience from Turkey}, congress name={IASLC 19th World Conference on Lung Cancer (WCLC 2018)}, city={Toronto}, country={Canada}, year={2018}}